Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
826
BlackBerry
BB
$5.23B
| $16.4M | 0.02% |
3,363,043
-5,742,200
| -63% | -$22.8M |
2024 Q4
3 quarters
|
|
827
First Trust Preferred Securities and Income ETF
FPE
$5.97B
| $16.4M | 0.02% |
898,623
+193,885
| +28% | +$3.5M |
2025 Q1
2 quarters
|
|
828
CareTrust REIT
CTRE
$8.51B
| $16.4M | 0.02% |
472,500
-384,838
| -45% | -$12.7M |
2023 Q3
8 quarters
|
|
829
Sensient Technologies
SXT
$5.55B
| $16.4M | 0.02% |
174,400
+133,352
| +325% | +$14.6M |
2025 Q1
2 quarters
|
|
|
APLS
830
DELISTED
Apellis Pharmaceuticals
APLS
| $16.4M | 0.02% |
722,895
+711,907
| +6,479% | +$16.6M |
2025 Q2
1 quarter
|
|
|
USAR
831
USA Rare Earth Inc
USAR
$4.71B
| $16.4M | 0.02% |
+951,400
| New | +$13.6M |
2025 Q3
0 quarters
|
|
832
Selective Insurance
SIGI
$5.02B
| $16.3M | 0.02% |
201,494
-39,000
| -16% | -$3.15M |
2023 Q3
8 quarters
|
|
833
MACOM Technology Solutions
MTSI
$25.2B
| $16.3M | 0.02% |
+131,215
| New | +$17.3M |
2025 Q3
0 quarters
|
|
834
Transmedics
TMDX
$2.7B
| $16.3M | 0.02% |
+145,199
| New | +$17M |
2025 Q3
0 quarters
|
|
835
Boise Cascade
BCC
$2.57B
| $16.3M | 0.02% |
210,249
+64,900
| +45% | +$5.56M |
2018 Q3
28 quarters
|
|
836
BioCryst Pharmaceuticals
BCRX
$2.18B
| $16.2M | 0.02% |
2,140,534
-386,200
| -15% | -$3.22M |
2023 Q3
8 quarters
|
|
837
KT
KT
$8.72B
| $16.2M | 0.02% |
832,593
+432,900
| +108% | +$8.82M |
2024 Q3
4 quarters
|
|
838
SPDR Gold MiniShares Trust
GLDM
$31B
| $16.2M | 0.02% |
+211,900
| New | +$14.5M |
2025 Q3
0 quarters
|
|
839
Southwest Gas
SWX
$6.1B
| $16.2M | 0.02% |
206,300
+110,500
| +115% | +$8.61M |
2025 Q1
2 quarters
|
|
840
MSC Industrial Direct
MSM
$7.23B
| $16.1M | 0.02% |
175,200
-62,400
| -26% | -$5.57M |
2021 Q4
15 quarters
|
|
841
Affiliated Managers Group
AMG
$10B
| $16M | 0.02% |
67,300
+22,900
| +52% | +$5.05M |
2022 Q1
14 quarters
|
|
842
Aurinia Pharmaceuticals
AUPH
$2.22B
| $16M | 0.02% |
1,449,600
+291,800
| +25% | +$3.19M |
2021 Q4
15 quarters
|
|
843
Metallus
MTUS
$829M
| $16M | 0.02% |
968,833
+300
| +0% | +$4.89K |
2020 Q1
22 quarters
|
|
844
Calix
CALX
$2.34B
| $16M | 0.02% |
260,818
+23,200
| +10% | +$1.34M |
2013 Q2
49 quarters
|
|
845
Cytokinetics
CYTK
$8.75B
| $15.9M | 0.02% |
289,967
+279,800
| +2,752% | +$11.5M |
2023 Q4
7 quarters
|
|
846
Haverty Furniture Companies
HVT
$425M
| $15.9M | 0.02% |
724,206
+6,600
| +0.9% | +$147K |
2013 Q2
49 quarters
|
|
847
ResMed
RMD
$32.4B
| $15.9M | 0.02% |
58,000
-45,000
| -44% | -$12.3M |
2024 Q2
5 quarters
|
|
848
Cooper-Standard Automotive
CPS
$373M
| $15.9M | 0.02% |
429,500
+87,700
| +26% | +$2.67M |
2022 Q1
14 quarters
|
|
849
Nektar Therapeutics
NKTR
$1.41B
| $15.8M | 0.02% |
278,541
+31,481
| +13% | +$1.04M |
2022 Q4
11 quarters
|
|
850
LeMaitre Vascular
LMAT
$1.85B
| $15.8M | 0.02% |
180,602
+21,902
| +14% | +$1.96M |
2020 Q4
19 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.